Physician profile
David M Packard
NPI 1558307173
$1,973.54
in general payments reported to CMS, 2019-2025
16 companies · $598 in 2025
The $598 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $348 · 2020: $47.35 · 2021: $235 · 2022: $333 · 2023: $202 · 2024: $211 · 2025: $598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,011.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,010.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $433.99 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $292.50 | 2020-2025 | Zerbaxa, Recarbrio, Dificid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $185.18 | 2021-2025 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Stryker Corporation | $151.03 | 2025 | Flowtriever |
| Janssen Pharmaceuticals, INC | $145.66 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $124.88 | 2021 | |
| Fresenius USA Marketing, INC. | $121.07 | 2019 | |
| Intuitive Surgical, INC. | $99.79 | 2025 | |
| Novo Nordisk INC | $98.37 | 2019 | |
| Pfizer INC. | $86.48 | 2022-2025 | |
| Ani Pharmaceuticals, INC. | $81.80 | 2022 | |
| Allergan, INC. | $54.74 | 2019 | |
| Edwards Lifesciences Corporation | $29.00 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Atricure, INC. | $28.15 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| E.R. Squibb & Sons, L.L.C. | $27.97 | 2023 | Eliquis |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $12.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Packard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.